Hester Biosciences Ltd

Hester Bios Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Hester Biosciences Ltd

₹ 1,787 -1.23%
03 Jun - close price
hester.in BSE: 524669 NSE: HESTERBIO
About

Hester Biosciences Ltd is one of the leading animal health care companies & the second largest poultry vaccine manufacturer in India. Founded by Mr. Rajiv Gandhi in 1987, it has now a presence in over 30 countries & has a key market in India, Nepal & Tanzania. It has partnered with Bill & Melinda Gates Foundation, GALVmed, Golchha Organisation, Novapharma, etc. While operating across four broad verticals of Poultry Vaccines, Poultry Health Products, Animal Vaccines and Animal Health Products, the company provides services like seroprofiling kits and diagnostic labs for poultry flocks, and mastitis control programs for cattle.[1]

Key Points

Market Share
The company is the world’s largest manufacturer and supplier of PPR vaccines, having ~75% of the world market. It has a 70%+ market share in Goat Pox vaccine in India. It is also the second largest poultry vaccine manufacturer, with ~35% market share in India. [1]

Website BSE NSE
  • Market Cap ₹ 1,520 Cr.
  • Current Price ₹ 1,787
  • High / Low ₹ 3,379 / 1,243
  • Stock P/E 47.7
  • Book Value ₹ 399
  • Dividend Yield 0.34 %
  • ROCE 10.6 %
  • ROE 9.77 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Company has been maintaining a healthy dividend payout of 19.5%

Cons

  • Stock is trading at 4.48 times its book value
  • The company has delivered a poor sales growth of 11.1% over past five years.
  • Company has a low return on equity of 10.0% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Part of BSE Healthcare BSE SmallCap BSE Allcap

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
50.25 50.53 72.00 70.77 60.70 80.35 66.43 65.51 72.87 73.47 73.50 62.83 76.67
40.20 41.33 56.22 51.78 49.78 68.99 54.43 53.94 60.45 59.97 58.77 53.81 62.97
Operating Profit 10.05 9.20 15.78 18.99 10.92 11.36 12.00 11.57 12.42 13.50 14.73 9.02 13.70
OPM % 20.00% 18.21% 21.92% 26.83% 17.99% 14.14% 18.06% 17.66% 17.04% 18.37% 20.04% 14.36% 17.87%
1.08 1.23 2.18 0.96 0.95 0.86 1.22 0.98 1.20 1.06 1.35 1.30 1.06
Interest 1.38 1.27 1.74 3.14 0.35 0.94 1.48 1.37 1.31 1.13 1.40 1.59 1.25
Depreciation 2.55 2.39 2.34 2.44 2.62 2.55 2.58 2.57 2.08 2.12 2.19 2.24 2.03
Profit before tax 7.20 6.77 13.88 14.37 8.90 8.73 9.16 8.61 10.23 11.31 12.49 6.49 11.48
Tax % 31.25% 26.14% 25.43% 25.40% 29.66% 26.00% 25.87% 24.85% 27.37% 25.38% 25.22% 31.59% 16.11%
4.95 5.01 10.35 10.73 6.26 6.47 6.78 6.48 7.43 8.43 9.34 4.44 9.64
EPS in Rs 5.82 5.89 12.17 12.61 7.36 7.61 7.97 7.62 8.73 9.91 10.98 5.22 11.33
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
69 90 101 123 135 171 169 208 219 254 285 286
43 64 67 82 85 103 117 136 159 199 238 236
Operating Profit 25 26 34 41 50 68 53 72 61 55 47 51
OPM % 37% 29% 34% 33% 37% 40% 31% 35% 28% 22% 17% 18%
1 3 1 1 2 3 3 -4 5 5 4 5
Interest 6 4 4 3 2 4 5 4 2 6 5 5
Depreciation 5 5 6 6 5 8 9 10 10 10 10 9
Profit before tax 14 19 25 33 44 60 41 55 53 44 37 42
Tax % 29% 26% 23% 25% 30% 27% 24% 27% 26% 26% 26% 24%
10 14 19 25 31 44 31 40 40 32 27 32
EPS in Rs 11.86 16.45 22.59 29.32 35.92 51.55 36.70 46.90 46.46 38.02 31.93 37.43
Dividend Payout % 17% 19% 18% 18% 28% 21% 18% 21% 22% 21% 19% 19%
Compounded Sales Growth
10 Years: 12%
5 Years: 11%
3 Years: 9%
TTM: 0%
Compounded Profit Growth
10 Years: 10%
5 Years: 1%
3 Years: -7%
TTM: 17%
Stock Price CAGR
10 Years: 12%
5 Years: 7%
3 Years: -8%
1 Year: 8%
Return on Equity
10 Years: 16%
5 Years: 13%
3 Years: 10%
Last Year: 10%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 9 9 9 9 9 9 9 9 9 9 9 9
Reserves 67 76 92 114 138 171 195 229 260 284 304 331
35 39 39 39 43 38 48 16 122 164 134 104
17 17 20 17 22 23 26 29 34 89 103 103
Total Liabilities 129 140 159 178 210 240 277 282 424 546 550 546
51 57 62 61 67 101 96 87 84 108 103 111
CWIP 13 14 10 21 30 0 1 4 82 149 171 177
Investments 4 9 9 9 14 28 41 44 65 65 65 65
61 61 78 88 99 111 139 148 194 224 210 193
Total Assets 129 140 159 178 210 240 277 282 424 546 550 546

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
11 20 19 28 32 36 26 41 16 33 43 64
-14 -12 -6 -15 -26 -25 -21 -4 -111 -72 -21 -19
3 -5 -12 -6 -6 -20 -1 -41 95 41 -24 -46
Net Cash Flow -0 3 1 6 -0 -9 3 -4 0 3 -2 -1

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 75 72 95 79 86 70 96 80 95 118 110 103
Inventory Days 1,145 431 627 356 493 511 754 390 404 362 251 228
Days Payable 143 68 109 80 100 85 170 96 63 131 110 127
Cash Conversion Cycle 1,076 434 614 355 480 496 681 374 436 349 250 204
Working Capital Days 195 137 165 139 160 167 197 205 230 222 200 178
ROCE % 20% 18% 22% 24% 26% 31% 20% 25% 17% 12% 9% 11%

Shareholding Pattern

Numbers in percentages

Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
53.73% 53.73% 53.73% 53.73% 53.73% 53.73% 53.73% 53.73% 53.73% 53.73% 53.73% 53.73%
0.72% 0.62% 0.45% 0.45% 0.45% 0.42% 0.43% 0.43% 0.52% 0.61% 0.59% 0.87%
0.04% 0.03% 0.03% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.02% 0.02%
45.51% 45.60% 45.77% 45.81% 45.82% 45.84% 45.83% 45.84% 45.74% 45.66% 45.65% 45.38%
No. of Shareholders 13,43913,71113,39113,12012,98413,34213,45012,84411,30511,53811,47311,853

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls